Related references
Note: Only part of the references are listed.The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review
Nina Ramessar et al.
LUPUS (2022)
The omega-3 index is inversely associated with the neutrophil-lymphocyte ratio in adults
Michael I. McBurney et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2022)
Silica Induction of Diverse Inflammatory Proteome in Lungs of Lupus-Prone Mice Quelled by Dietary Docosahexaenoic Acid Supplementation
Lichchavi D. Rajasinghe et al.
FRONTIERS IN IMMUNOLOGY (2022)
CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
Zeqi Shi et al.
MOLECULES (2022)
Single cell analysis of docosahexaenoic acid suppression of sequential LPS-induced proinflammatory and interferon-regulated gene expression in the macrophage
Kathryn A. Wierenga et al.
FRONTIERS IN IMMUNOLOGY (2022)
Fatty Acid and Antioxidant Profile of Eggs from Pasture-Raised Hens Fed a Corn- and Soy-Free Diet and Supplemented with Grass-Fed Beef Suet and Liver
Selin Sergin et al.
FOODS (2022)
The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
Wenlin Qiu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Update on the diagnosis and management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation
Zhen Cui et al.
HYPERTENSION (2021)
A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis
Deepa Jonnalagadda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Tao Cheng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Omega-3 Polyunsaturated Fatty Acid Intervention Against Established Autoimmunity in a Murine Model of Toxicant-Triggered Lupus
James J. Pestka et al.
FRONTIERS IN IMMUNOLOGY (2021)
Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease
Michael Battaglia et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
Prae Charoenwoodhipong et al.
ARTHRITIS CARE & RESEARCH (2020)
sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions
Zhihui Chen et al.
SHOCK (2020)
The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus
Michelle D. Catalina et al.
JOURNAL OF AUTOIMMUNITY (2020)
Tris DBA Ameliorates Accelerated and Severe Lupus Nephritis in Mice by Activating Regulatory T Cells and Autophagy and Inhibiting the NLRP3 Inflammasome
Chung-Yao Wu et al.
JOURNAL OF IMMUNOLOGY (2020)
Lipids in Parenteral Nutrition: Biological Aspects
Philip C. Calder et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2020)
Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
Carlos A. Trindade-da-Silva et al.
FASEB JOURNAL (2020)
Xenon blunts NF-κB/NLRP3 inflammasome activation and improves acute onset of accelerated and severe lupus nephritis in mice
Shin-Ruen Yang et al.
KIDNEY INTERNATIONAL (2020)
Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression
Julie Lasselin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Are lupus animal models useful for understanding and developing new therapies for human SLE?
Erica Moore et al.
JOURNAL OF AUTOIMMUNITY (2020)
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
Fabio Basta et al.
RHEUMATOLOGY AND THERAPY (2020)
Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice
Lichchavi D. Rajasinghe et al.
AUTOIMMUNITY (2020)
Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis
Ali Duarte-Garcia et al.
AUTOIMMUNITY REVIEWS (2020)
Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis
Shin-Ruen Yang et al.
FASEB JOURNAL (2020)
Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring
Kathryn A. Wierenga et al.
FRONTIERS IN IMMUNOLOGY (2020)
Omega-3 Docosahexaenoic Acid (DHA) Impedes Silica-Induced Macrophage Corpse Accumulation by Attenuating Cell Death and Potentiating Efferocytosis
Lichchavi D. Rajasinghe et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration
Morteza Sarparast et al.
NUTRIENTS (2020)
Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
Xiayun Wan et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis
Weicang Wang et al.
CANCER RESEARCH (2019)
Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation
Sean D. Kodani et al.
BIOCHIMIE (2019)
In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
Debin Wan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice
Jan Klocke et al.
SCIENTIFIC REPORTS (2019)
Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice
Tsai-Jung Lin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Docosahexaenoic Acid Suppresses Silica-Induced Inflammasome Activation and IL-1 Cytokine Release by Interfering With Priming Signal
Kathryn A. Wierenga et al.
FRONTIERS IN IMMUNOLOGY (2019)
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases
Xiaoxi Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Moving Forward With Biologics in Lupus Nephritis
Liliane Hobeika et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2019)
Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens
Connie C. Qiu et al.
FRONTIERS IN IMMUNOLOGY (2019)
New therapeutic strategies in systemic lupus erythematosus management
Mariele Gatto et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Docosahexaenoic Acid Consumption Impedes Early Interferon- and Chemokine-Related Gene Expression While Suppressing Silica-Triggered Flaring of Murine Lupus
Abby D. Benninghoff et al.
FRONTIERS IN IMMUNOLOGY (2019)
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of alpha-Synuclein Aggregation and ER Stress
Hui-Ju Huang et al.
MOLECULAR NEUROBIOLOGY (2018)
20-HETE Hypertension and Beyond
Richard J. Roman et al.
HYPERTENSION (2018)
Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting
Christoph Schmoecker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption
M. H. Napimoga et al.
JOURNAL OF PERIODONTAL RESEARCH (2018)
Mechanisms of Tissue Injury in Lupus Nephritis
Giovanna Flores-Mendoza et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia
Ranran Tu et al.
SCIENTIFIC REPORTS (2018)
Dietary Docosahexaenoic Acid Prevents Silica-Induced Development of Pulmonary Ectopic Germinal Centers and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse
Melissa A. Bates et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Effects of sEH Inhibitor on Depression-like Behavior and Neurogenesis in Male Mice
Qiong Wu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
Feng Yu et al.
NATURE REVIEWS NEPHROLOGY (2017)
Retroconversion is a minor contributor to increases in eicosapentaenoic acid following docosahexaenoic acid feeding as determined by compound specific isotope analysis in rat liver
Adam H. Metherel et al.
NUTRITION & METABOLISM (2017)
Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling
Bing-Qing Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids
Annika I. Ostermann et al.
FOOD & FUNCTION (2017)
Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice
Yuxue Chen et al.
SCIENTIFIC REPORTS (2017)
Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice
Yong Zhou et al.
CELL AND TISSUE RESEARCH (2016)
An ω-3-enriched diet alone does not attenuate CCl4-induced hepatic fibrosis
Todd R. Harris et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress
Qian Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
CYP450-derived oxylipins mediate inflammatory resolution
Derek W. Gilroy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption
Melissa A. Bates et al.
PLOS ONE (2016)
Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers
Sumanta Kumar Goswami et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Soluble Epoxide Hydrolase Inhibitor Attenuates Inflammation and Airway Hyperresponsiveness in Mice
Jun Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus
Kongyang Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
Annika I. Ostermann et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice
Todd R. Harris et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation
Shuk-Man Ka et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review
Andreas Kronbichler et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
SLE: Another Autoimmune Disorder influenced by Microbes and Diet?
Qinghui Mu et al.
FRONTIERS IN IMMUNOLOGY (2015)
Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides
Cristina Lopez-Vicario et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice
Ahmed Bettaieb et al.
MOLECULAR PHARMACOLOGY (2015)
20-HETE and Blood Pressure Regulation Clinical Implications
Cheng-Chia Wu et al.
CARDIOLOGY IN REVIEW (2014)
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Yu Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Expert Panel Workshop Consensus Statement on the Role of the Environment in the Development of Autoimmune Disease
Christine G. Parks et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Outer Membrane Remodeling: The Structural Dynamics and Electrostatics of Rough Lipopolysaccharide Chemotypes
Roberta P. Dias et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2014)
Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy
Kin Sing Stephen Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Comparative Effects of n-3, n-6 and n-9 Unsaturated Fatty Acid-Rich Diet Consumption on Lupus Nephritis, Autoantibody Production and CD4+ T Cell-Related Gene Responses in the Autoimmune NZBWF1 Mouse
James J. Pestka et al.
PLOS ONE (2014)
Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models
Jun-Yan Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Concentrated fish oil (Lovaza®) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice
Ganesh V. Halade et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Intact rough- and smooth-form lipopolysaccharides from Escherichia coli separated by preparative gel electrophoresis exhibit differential biologic activity in human macrophages
Elder Pupo et al.
FEBS JOURNAL (2013)
Anti-inflammatory Effects of ω-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II-Dependent Hypertension
Arzu Ulu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo
Suman Kundu et al.
JOURNAL OF LIPID RESEARCH (2013)
Epoxyeicosanoids promote organ and tissue regeneration
Dipak Panigrahy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis
Guodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease
Lei Wang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis
Pei-Yi Tsai et al.
ARTHRITIS AND RHEUMATISM (2012)
Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys
A. Ulu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Soluble Epoxide Hydrolase Inhibitors and Heart Failure
Hong Qiu et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation
Pei-Yi Tsai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Therapeutic potential of DCB-SLE1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis
Pei-Yi Tsai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Lipopolysaccharide from Gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice
T. CAVALLO et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice
N. A. GRANHOLM et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes
Tai-Ping Lee et al.
JOURNAL OF AUTOIMMUNITY (2010)
Docosahexaenoic Acid-Enriched Fish Oil Attenuates Kidney Disease and Prolongs Median and Maximal Life Span of Autoimmune Lupus-Prone Mice
Ganesh V. Halade et al.
JOURNAL OF IMMUNOLOGY (2010)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Epoxyeicosatrienoic acids and endothelium-dependent responses
William B. Campbell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Arachidonic acid cytochrome P450 epoxygenase pathway
Arthur A. Spector
JOURNAL OF LIPID RESEARCH (2009)
EET displays anti-inflammatory effects in TNF-α-stimulated human bronchi
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis
H.-A. Shui et al.
RHEUMATOLOGY (2007)
R-form LPS, the master key to the activation of TLR4/MD-2-positive cells
M Huber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD14 is required for MyD88-independent LPS signaling
ZF Jiang et al.
NATURE IMMUNOLOGY (2005)
11,12-Epoxyeicosatrienoic acid (11,12-EET):: Structural determinants for inhibition of TNF-α-induced VCAM-1 expression
JR Falck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The pathogenesis of autoimmunity in New Zealand mice
A Borchers et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
Share Paper
